| abstract |
A group of intranasal spray dispensers is disclosed for administering a uniform low dose of desmopressin to achieve safe antidiuresis in human patients. The dispenser of the present invention may be useful for treatment of nocturnal enuresis, primary nocturnal enuresis, urinary incontinence, urinary insufficiency, or desmopressin therapy, or a safe temporary inhibition of urine production may lead to beneficial health effects or increased convenience in urination control. It can be used in the treatment of any disease or syndrome present. |